MSGV1-PSCA-8T28Z
- Generic Name
- MSGV1-PSCA-8T28Z
Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC
Phase 1
Recruiting
- Conditions
- Metastatic Castration-resistant Prostate Cancer
- Interventions
- First Posted Date
- 2024-01-05
- Last Posted Date
- 2025-03-27
- Target Recruit Count
- 30
- Registration Number
- NCT06193486
- Locations
- 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath